Showing 5921-5930 of 21466 results for "".
- Understanding Patient Priorities in Bladder Cancer Treatmenthttps://reachmd.com/news/understanding-patient-priorities-in-bladder-cancer-treatment/2484077/As treatment options for muscle-invasive bladder cancer (MIBC) continue to evolve—with immunotherapy and bladder-sparing protocols reshaping the landscape—a new study brings a crucial voice into the conversation: that of the patient.
- Emerging Biomarkers in Pediatric NAFLD: Beyond BMIhttps://reachmd.com/news/emerging-biomarkers-in-pediatric-nafld-beyond-bmi/2484084/In a prospective sample of 199 children, the triglyceride‑to‑HDL‑cholesterol ratio and the triglyceride‑glucose (TyG) index showed markedly higher sens
- Dr. Peter Lio Named Fall Clinical Educator of the Yearhttps://reachmd.com/news/dr-peter-lio-named-fall-clinical-educator-of-the-year/2484092/Peter Lio, MD, was presented with the Educator of the Year Award at the 2025 Fall Clinical Dermatology Conference. Dr. Lio is founding director of the Chicago Integrative Eczema Center and a member of Practical Dermatology’s Editorial Board. Dr. Lio spoke at the Fall Clinical Meetin
- New Deuruxolitinib Data Show It Meets 'The Need for Speed'https://reachmd.com/news/new-deuruxolitinib-data-show-it-meets-the-need-for-speed/2484089/Deuruxolitinib resulted in significant hair regrowth starting at Week 8, continually improving through Week 24, and the 8-mg and 12-mg BID doses showed significant efficacy vs placebo across subgroups, according to new data presented at the 2025 Fall Clinical Dermatology Conference. Other
- Arcutis Presents New ZORYVE Data in AD at Fall Clinical 2025https://reachmd.com/news/arcutis-presents-new-zoryve-data-in-ad-at-fall-clinical-2025/2484062/Updates and new data sets from the INTEGUMENT trial program, including new quality-of-life and efficacy data for ZORYVE® (roflumilast) cream in pediatric and adult patients with atopic dermatitis (AD), were featured at the 2025 Fall Clinical Dermatology Conference
- Phthalates May Heighten Cardiovascular Risk in Patients with CKDhttps://reachmd.com/news/phthalates-may-heighten-cardiovascular-risk-in-patients-with-ckd/2484033/In a new study that deepens concerns about environmental pollutants in vulnerable populations, researchers have identified a significant link between phthalate exposure and ca
- Seoul Virus Case in Germany Exposes Weaknesses in Zoonotic Disease Managementhttps://reachmd.com/news/seoul-virus-case-in-germany-exposes-weaknesses-in-zoonotic-disease-management/2484039/A human Seoul virus case in Germany has been genomically linked to a private rat-breeding facility, highlighting diagnostic and biosafety gaps with direct clinical and laboratory relevance. Evaluation of suspected hantavirus infection in the
- AAFPRS Highlights Energy-Based Device Trends Defining Aesthetic Advancements in 2025https://reachmd.com/news/aafprs-highlights-energy-based-device-trends-defining-aesthetic-advancements-in-2025/2484060/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) is spotlighting the latest innovations in energy-based devices (EBDs), signaling a shift toward increasingly personalized, nonsurgical facial rejuvenation in 2025.
- Key Updates in the 2025 AHA CPR Guidelineshttps://reachmd.com/news/key-updates-in-the-2025-aha-cpr-guidelines/2484032/The American Heart Association’s 2025 CPR guidelines introduce critical changes to enhance clarit
- Cannabidiol-Derived Compounds Show Potent Effects Against SARS-CoV-2https://reachmd.com/news/cannabidiol-derived-compounds-show-potent-effects-against-sars-cov-2/2484029/Researchers in Brazil have identified two novel synthetic compounds derived from cannabidiol (CBD) that demonstrate striking antiviral and anti-inflammatory effects against SARS-CoV-2. The findings, published